Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Usrenty
(ustekinumab)
Uses, side effects, dosage information & price range
About this medicine
Plaque psoriasis Usrenty is indicated for the treatment of moderate to severe plaque psoriasis in adults who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including ciclosporin, methotrexate (MTX) or PUVA (psoralen and ultraviolet A). Paediatric plaque psoriasis Usrenty is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescent patients from the age of 6 years and older, who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies. Psoriatic arthritis (PsA) Usrenty, alone or in combination with MTX, is indicated for the treatment of active psoriatic arthritis in adult patients when the response to previous non-biological disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate. Crohns Disease Usrenty is indicated for the treatment of adult patients with moderately to severely active Crohns disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a TNF? antagonist.
Common Brand Names for this Composition
The following popular commercial brand names contain ustekinumab as their active ingredient composition:
Usrenty
Biosimilar Collaborations Ireland Limited
Imuldosa
Accord Healthcare S.L.U.
Uzpruvo
Stada Arzneimittel AG
Usgena
Stada Arzneimittel AG
Stelara
Janssen-Cilag International NV
Steqeyma
Celltrion Healthcare Hungary Kft.
Qoyvolma
Celltrion Healthcare Hungary Kft.
Otulfi
Fresenius Kabi Deutschland GmbH
Fymskina
Formycon AG
Wezenla
Amgen Technology (Ireland) UC
Yesintek
Biosimilar Collaborations Ireland Limited
Usymro
Gedeon Richter Plc.
Absimky
Accord Healthcare S.L.U.
Pyzchiva
Samsung Bioepis NL B.V.
Eksunbi
Samsung Bioepis NL B.V.
Upstelda
Amgen Technology (Ireland) UC
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
ustekinumab
Category
Immunosuppressants
Manufacturer
Biosimilar Collaborations Ireland Limited
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.